Back
Rocket Pharmaceuticals Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
33
RCKT
Rocket Pharmaceuticals
Last Price:
$6.54
Seasonality Move:
13.7%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight buying pressure.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.68 | Buy |
| 20-day SMA: | 7.07 | Sell |
| 50-day SMA: | 7.18 | Sell |
| 200-day SMA: | 13.31 | Sell |
| 8-day EMA: | 6.76 | Sell |
| 20-day EMA: | 6.89 | Sell |
| 50-day EMA: | 7.51 | Sell |
| 200-day EMA: | 12.44 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 47.6 | Sell |
| Chaikin Money Flow: | 2702803 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.06 - 7.56) | Sell |
| Bollinger Bands (100): | (6.89 - 11.13) | Sell |
Rocket Pharmaceuticals Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 6.73 while RCKT 8-day simple moving average is 6.68, which is a Buy signal.
-
The stock price of RCKT is 6.73 while Rocket Pharmaceuticals 20-day SMA is 7.07, which makes it a Sell.
-
Rocket Pharmaceuticals 50-day simple moving average is 7.18 while RCKT share price is 6.73, making it a Sell technically.
-
RCKT stock price is 6.73 and Rocket Pharmaceuticals 200-day simple moving average is 13.31, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
33
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a SellThe current Rocket Pharmaceuticals [RCKT] share price is $6.73. The Score for RCKT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
724.5M
Price in USD:
6.73
Share Volume:
6.5M
Rocket Pharmaceuticals 52-Week Range
52-Week High:
26.98
52-Week Low:
4.55
Sell
33
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?The Rocket Pharmaceuticals stock price is 6.73 USD today.
-
Will RCKT stock go up or go down?Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rocket Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 6.73 while RCKT 8-day exponential moving average is 6.76, which is a Sell signal.
-
The stock price of RCKT is 6.73 while Rocket Pharmaceuticals 20-day EMA is 6.89, which makes it a Sell.
-
Rocket Pharmaceuticals 50-day exponential moving average is 7.51 while RCKT share price is 6.73, making it a Sell technically.
-
RCKT stock price is 6.73 and Rocket Pharmaceuticals 200-day simple moving average is 12.44, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.24 per share, an increase this year of $0.60 per share, and an increase next year of $0.61 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
-
RCKT Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Rocket Pharmaceuticals is a Sell
-
Rocket Pharmaceuticals Relative Strength Index (RSI) is 47.6, which suggest Rocket Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Rocket Pharmaceuticals is (6.06 - 7.56), which suggest Rocket Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Rocket Pharmaceuticals is (6.89 - 11.13), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.